13D Filing: Elliott Associates, L.P. and Imperva Inc (IMPV)

Page 5 of 8 – SEC Filing

The following constitutes Amendment No. 2 to the Schedule 13D filed by the undersigned (the “Amendment No. 2”).  This Amendment No. 2 amends the Schedule 13D as specifically set forth herein.
Item 3.
Source and Amount of Funds or Other Consideration.
Item 3 is hereby amended and restated to read as follows:
Elliott Working Capital
The aggregate purchase price of the shares of Common Stock directly owned by Elliott is approximately $25,715,950.
Elliott International Working Capital
The aggregate purchase price of the shares of Common Stock directly owned by Elliott International is approximately $54,963,751.
The Reporting Persons may effect purchases of shares of Common Stock through margin accounts maintained for them with prime brokers, which extend margin credit as and when required to open or carry positions in their margin accounts, subject to applicable federal margin regulations, stock exchange rules and such firms’ credit policies. Positions in shares of Common Stock may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts. Since other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase shares of Common Stock.
Item 4.
Purpose of Transaction.
Item 4 is hereby amended to add the following:
The Reporting Persons are pleased with the operational progress achieved at the Company over the last year, including its recent revenue growth of 29% last quarter and its significant operating income improvement.  In addition, the Reporting Persons are highly supportive of the Company’s new CEO Chris Hylen, who had a strong track record as the CEO of Citrix GetGo.  With the Issuer’s share price appreciating meaningfully from the Reporting Persons’ cost basis, the Reporting Persons have reduced their position in the Issuer but remain sizable investors and a top 5 shareholder in the Issuer.
ITEM 5.
Interest in Securities of the Issuer.
Item 5(a) is hereby amended and restated to read as follows:
(a) As of the close of business on September 12, 2017, Elliott, Elliott International and EICA collectively have combined economic exposure in the Issuer of approximately 9.5% of the shares of Common Stock outstanding.
The aggregate percentage of Common Stock reported owned by each person named herein is based upon 33,814,837 shares of Common Stock outstanding as of July 31, 2017, which is the total number of shares of Common Stock outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 3, 2017.
As of the close of business on September 12, 2017, Elliott beneficially owned 719,724 shares of Common Stock, constituting approximately 2.1% of the shares of Common Stock outstanding.
As of the close of business on September 12, 2017, Elliott International beneficially owned 1,529,413 shares of Common Stock, constituting approximately 4.5% of the shares of Common Stock outstanding. EICA, as the investment manager of Elliott International, may be deemed to beneficially own the 1,529,413 shares of Common Stock beneficially owned by Elliott International, constituting approximately 4.5% of the shares of Common Stock outstanding.
Collectively, Elliott, Elliott International and EICA beneficially own 2,249,137 shares of Common Stock, constituting approximately 6.7% of the shares of Common Stock outstanding.
Collectively, Elliott, Elliott International and EICA have economic exposure comparable to approximately 2.8% of the shares of Common Stock outstanding pursuant to the Derivative Agreements, as disclosed in Item 6.

Follow Imperva Inc (NYSE:IMPV)